The US International Trade Commission will probe whether a competitor is infringing Sartorius Bioanalytical Instruments Inc.'s biotech patents covering “certain bio-layer interferometers and components” used in molecule analysis and drug development.
The investigation, announced Tuesday, responds to an Oct. 25 complaint in which New York-based Sartorius claimed Palo Alto firm Gator Bio Inc.'s line of instruments—including its GatorPrime and GatorPlus biosensing products used in lab tests—copy its patented technology. If the ITC agrees, the products would be blocked from US importation and sales.
Sartorius, which asserted US Patent Nos. 7,394,547, 7,445,887, 7,728,982, and 8,305,585 against Gator, said ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.